This supplemental application to the UPR-MSC's MBRS SCORE Program expands the scope of support for biomedical research provided by the parent program, thereby strengthening its ability to attain the overall goal of assisting faculty to develop competitive research programs, and increasing the number of underrepresented minorities professionally engaged in biomedical, clinical and behavioral research. As an outcome of our recent competing renewal process, the SCORE Program is currently composed of 22 projects (18 regular and 4 pilots), that integrates investigators from four out of six MSC's schools and colleges. The main research focus areas supported by the program are: Infectious Diseases, Neurosciences, Cell Biology, Cancer, and Molecular Toxicology. The new cadre of investigators and projects in this supplement complement the parent grant by increasing the mass of PIs in the main research areas. In addition, the diversity of research topics within these areas is further expanded with one project being in Cardiovascular Physiology, and two projects in Infectious Diseases. Specifically, the supplement seeks support for 3 projects (2 regular and one pilot) to include faculty who are at an early stage of professional development. Support of all applicants in this supplement is consequently envisioned as a significant added value and asset accrual for UPR-MSC's and national MBRS SCORE Programs. Once awarded, the prospective PI profile will result in an SCORE Program sensitive to all stages of career development, primarily addressing PIs at the end of the spectrum of highest developmental assistance (stages 1-3). All subprojects included are revised applications that thoroughly considered the critiques raised in the previous supplemental application, considerably strengthening their scientific merit. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Minority Biomedical Research Support - MBRS (S06)
Project #
3S06GM008224-22S1
Application #
7137605
Study Section
Minority Programs Review Committee (MPRC)
Program Officer
Toliver, Adolphus
Project Start
1997-08-01
Project End
2008-07-31
Budget Start
2006-08-01
Budget End
2007-07-31
Support Year
22
Fiscal Year
2006
Total Cost
$325,573
Indirect Cost
Name
University of Puerto Rico Med Sciences
Department
Physiology
Type
Schools of Medicine
DUNS #
948108063
City
San Juan
State
PR
Country
United States
Zip Code
00936
Rijpma, Sanna R; van der Velden, Maarten; González-Pons, Maria et al. (2016) Multidrug ATP-binding cassette transporters are essential for hepatic development of Plasmodium sporozoites. Cell Microbiol 18:369-83
Padín-Irizarry, Vivian; Colón-Lorenzo, Emilee E; Vega-Rodríguez, Joel et al. (2016) Glutathione-deficient Plasmodium berghei parasites exhibit growth delay and nuclear DNA damage. Free Radic Biol Med 95:43-54
Jardón, Javier; Izquierdo, Natalio J; Renta, Jessica Y et al. (2016) Ocular Findings in Patients with the Hermansky-Pudlak Syndrome (Types 1 and 3). Ophthalmic Genet 37:89-94
Rivera-Peña, Bianca; Ruíz-Fullana, Francisco J; Vélez-Reyes, Germán L et al. (2016) HPV-16 infection modifies overall survival of Puerto Rican HNSCC patients. Infect Agent Cancer 11:47
Velásquez-Martínez, Maria C; Vázquez-Torres, Rafael; Rojas, Legier V et al. (2015) Alpha-1 adrenoreceptors modulate GABA release onto ventral tegmental area dopamine neurons. Neuropharmacology 88:110-21
Vega-Rodríguez, Joel; Pastrana-Mena, Rebecca; Crespo-Lladó, Keila N et al. (2015) Implications of Glutathione Levels in the Plasmodium berghei Response to Chloroquine and Artemisinin. PLoS One 10:e0128212
Zenón, Frances; Cantres-Rosario, Yisel; Adiga, Radhika et al. (2015) HIV-infected microglia mediate cathepsin B-induced neurotoxicity. J Neurovirol 21:544-58
Ortiz, A P; Unger, E R; Muñoz, C et al. (2014) Cross-sectional study of HPV-16 infection in a population-based subsample of Hispanic adults. BMJ Open 4:e004203
Rosas, Odrick R; Torrado, Aranza I; Santiago, Jose M et al. (2014) Long-term treatment with PP2 after spinal cord injury resulted in functional locomotor recovery and increased spared tissue. Neural Regen Res 9:2164-73
Mosquera, Laurivette; Colón, Jennifer M; Santiago, José M et al. (2014) Tamoxifen and estradiol improved locomotor function and increased spared tissue in rats after spinal cord injury: their antioxidant effect and role of estrogen receptor alpha. Brain Res 1561:11-22

Showing the most recent 10 out of 174 publications